News | Computer-Aided Detection Software | March 15, 2017

Company will demonstrate AccuDetect CAD for Mammography

Parascript, AccuDetect CAD for Mammography, computer-aided detection, NCoBC 2017

March 15, 2017 — Parascript will exhibit at the National Consortium of Breast Centers (NCoBC) 27th Conference, March 11-17, 2017, in Las Vegas, where the company will provide a demo of its AccuDetect Computer-Aided Detection (CAD) for Mammography.

Established in 1985, the National Consortium of Breast Centers is an interdisciplinary organization created to ensure quality patient care at breast centers through education, certification and interdisciplinary communication. The consortium is dedicated to improving the outcomes of breast care patients and assisting healthcare providers. In its 27th year, the conference brings together breast health professionals, technology experts and equipment specialists as well as drug and service providers to demonstrate the latest technology and breast care options available.

At NCoBC, Parascript will demonstrate AccuDetect CAD, which uses multiple independent cancer detection algorithms and a patented voting methodology to combine its findings. Comparing the results of the multiple image recognition processes allows for improved sensitivity and reduced false-positive rates, resulting in precise CAD markings for areas of interest.

Hospitals throughout the country have commented on AccuDetect’s rapid processing capabilities, according to Parascript. The company said AccuDetect CAD processes breast images significantly faster than the top competition with a processing time of just 11 seconds per image, and 45 seconds per four-view study. The average CAD system takes 30 seconds or more to process a single image.

“Having Parascript software sets us apart from what is going on around us. It lets people know that we are serious about taking care of their health and taking care of their families,” said Ronnie Dillion, director of radiology at the Ashley County Medical Center, Crossett, Ark.

For more information: www.parascript.com


Related Content

News | Breast Imaging

July 30, 2026 — DeepHealth, Inc. has received FDA 510(k) clearance for DeepHealth Breast Ultrasound1, an AI-powered ...

Time July 31, 2026
arrow
News | Computed Tomography (CT)

July 23, 2026 — HOPPR has introduced HOPPR EF Chest CT Narrative Model, a foundation model that processes 3D chest CT ...

Time July 27, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Women's Health

June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...

Time June 02, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
Subscribe Now